Description and Brand Names
المعلومات عن الأدوية مقدَّمة من: IBM Micromedex
US Brand Name
Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.
Enasidenib is an isocitrate dehydrogenase-2 inhibitor. It works by blocking the enzyme isocitrate dehydrogenase which is needed by the cancer cells to grow.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: